Skip to main content
Oriola Oyj logo

Oriola Oyj — Investor Relations & Filings

Ticker · OKDAV ISIN · FI0009014344 LEI · 549300UWB1AIR85BM957 HE Wholesale and retail trade
Open in API
Filings indexed 1,782 across all filing types
Latest filing 2024-12-19 Management Reports
Country FI Finland
Listing HE OKDAV

About Oriola Oyj

https://www.oriola.com/

Oriola is a health and wellbeing company providing pharmaceutical distribution, wholesale, and advisory services in the Nordic market. The company connects pharmaceutical companies and health product suppliers with pharmacies, healthcare providers, veterinarians, and retailers. Core services include GDP-compliant supply chain management, warehousing, and specialized logistics like cold chain and vaccine distribution. The wholesale business offers a broad product range and leverages deep market knowledge to facilitate market access. Advisory services support clients throughout the product lifecycle with expertise in market entry, regulatory compliance, and commercial strategy, ensuring operational efficiency and customer value.

Recent filings

Filing Released Lang Actions
Oriola kirjaa noin 16 miljoonan euron arvonalentumisen yhteisyritys Kronans Apotekiin liittyen
Management Reports Classification · 95% confidence The document is a stock exchange release (pörssitiedote) from Oriola Oyj announcing a specific financial event: a 16 million euro impairment charge related to their joint venture, Kronans Apotek. It details the impact on the Q4 2024 results and confirms that the company's outlook remains unchanged. As this is a specific regulatory announcement regarding a financial event rather than a full report or a routine publication notice, it falls under the category of general regulatory announcements.
2024-12-19 Finnish
Oriola to record an impairment of a..
Earnings Release Classification · 99% confidence The document is a short stock exchange release from Oriola Oyj dated December 19, 2024. It announces a specific, non-recurring financial event: an impairment charge of approximately EUR 16 million related to its joint venture, Kronans Apotek. This announcement details a specific financial adjustment that impacts the 'share of results in joint venture' for the fourth quarter. It is not a full Annual Report (10-K), an Interim Report (IR), or a general Earnings Release (ER) which typically covers all results. It is a specific disclosure about a financial event impacting results, which fits best under a general regulatory announcement or a specific financial update. Since it is a specific, material financial disclosure that is not a full report, and it is not related to capital structure, dividends, insider trading, or management changes, it falls under the general category for regulatory announcements that don't fit elsewhere, which is RNS (Regulatory Filings). However, given the content is a specific financial update (impairment), it is more specific than a generic RNS. It is not a Call Transcript (CT), Director's Dealing (DIRS), or Dividend Notice (DIV). It is a specific financial disclosure, but not a full earnings release or interim report. Given the options, RNS is the most appropriate fallback for a specific, material, non-standard financial disclosure that isn't a full report or a specific event like a merger or capital change. The document length is short (1577 chars), suggesting it is an announcement rather than the full report itself. Q4 2024
2024-12-19 English
Oriola kirjaa noin 16 miljoonan eur..
Legal Proceedings Report Classification · 99% confidence The document is a short press release from Oriola Oyj, dated 19.12.2024, announcing a specific financial event: an impairment charge of approximately 16 million euros related to its joint venture, Kronans Apotek. This announcement details the impact on the Q4 2024 results and confirms that the full year outlook remains unchanged. It also mentions the future release date of the full 2024 financial statements (4.3.2025). Since the text is a brief announcement detailing a specific financial event (impairment/write-down) that affects the period's results, it aligns best with an Earnings Release (ER) which covers key highlights, or potentially a Regulatory Filing (RNS) if it were purely regulatory. However, because it focuses specifically on a significant component of the period's financial performance (impairment charge impacting Q4 results), ER is the most appropriate fit among the specific financial categories, as it is a key highlight preceding the full report. It is not a full report (10-K or IR), nor is it a management discussion (MDA) or a general announcement (RPA/RNS).
2024-12-19 Finnish
12111730.pdf
Board/Management Information Classification · 100% confidence The document is a press release from Oriola Oyj announcing a restructuring of its operating model and changes to its executive management team (board/management). It details the new organizational structure and provides biographical information (CVs) for the newly appointed members of the management team. This fits the definition of 'Board/Management Information' (MANG).
2024-12-11 Finnish
Oriola uudistaa toimintamalliaan ja johtoryhmäänsä nopeuttaakseen strategian toteuttamista
Board/Management Information Classification · 100% confidence The document is a press release from Oriola Oyj announcing a restructuring of its operating model and changes to its executive management team (johtoryhmä). It details the new organizational structure, the appointment of new members to the leadership team, and provides their professional backgrounds (CVs). This falls squarely under the 'Board/Management Information' category as it pertains to senior management changes and organizational governance.
2024-12-11 Finnish
12111731.pdf
Board/Management Information Classification · 100% confidence The document is a stock exchange release from Oriola Corporation announcing a renewal of its operating model and significant changes to its Management Team, including the appointment of new members. This content directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in a company's board of directors or senior management.
2024-12-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.